Cue Biopharma, Inc. (CUE) Insider Ownership

Data spanning the past 90 days through February 19, 2026 reveals that Cue Biopharma's three principal insider shareholders consist of Director Aaron G.L. Fletcher (940.00K shares), Director Cameron Gray (687.05K shares), Director Pasha Sarraf (323.86K shares).

• The shareholding composition of Cue Biopharma (CUE) reflects broad market participation, with institutional funds owning 20.46%, executive insider stakes representing 2.16%, with public and others accounting for 77.38%.
• Current insider holdings at Cue Biopharma account for 2.16% of total shares outstanding as of February 19, 2026, totaling roughly 2.30Mn shares from the company's 106.40Mn share base.
• Insider ownership levels at Cue Biopharma increased 7.43% across the 90-day window ending February 19, 2026, reflecting insider holdings that growing from 2.14Mn shares to 2.30Mn shares.
• During the 90-day window concluding February 19, 2026, Director Pasha Sarraf executed the largest insider acquisition at Cue Biopharma, purchasing 323.86K shares.
• Cue Biopharma had no significant insider sales in the last 90 days.